-
Active Trials
-
Phase 3
-
Phase 2
-
Phase 1
-
Results Pending
📊
Pipeline Summary
Expected Approvals
FDA Decision 1 upcoming PDUFA date
Mitapivat (PYRUKYND) Sickle cell disease in patients aged 16 and older (accelerated approval pathway) sNDA
Clinical Trials
Loading...